Could GLP-1 Drugs Help You Live Longer?

Weight-loss medications such as Ozempic and Zepbound have already transformed the treatment of obesity and type 2 diabetes. Researchers are now investigating whether these drugs could also promote healthier aging and extend lifespan.

Early findings suggest potential benefits. In one study, people living with HIV who took semaglutide—the active ingredient in Ozempic—for eight months showed biomarkers associated with slower biological aging. While encouraging, researchers emphasize that these results are preliminary and require further validation.

Scientists believe GLP-1 medications may support healthy aging by improving metabolic health, reducing chronic inflammation, and lowering the risk of age-related diseases such as diabetes and cardiovascular disease. These effects have fueled growing interest in their potential role in longevity.

However, experts caution that there is currently no conclusive evidence that GLP-1 drugs increase lifespan in healthy individuals. Potential side effects, including muscle loss and reduced bone density, also remain important considerations, particularly for older adults.

Several clinical trials are underway to determine whether these medications can influence biological aging, physical function, and long-term health outcomes. Until stronger evidence becomes available, specialists do not recommend using GLP-1 drugs solely for longevity purposes.

For now, the most effective strategies for healthy aging remain regular exercise, a balanced diet, maintaining a healthy weight, managing chronic conditions, getting adequate sleep, and avoiding smoking.

While GLP-1 therapies continue to show promise beyond weight management, their role as longevity medications has yet to be established.

Source: https://health.yahoo.com/wellness/healthy-aging/longevity/articles/could-weight-loss-drugs-longevity-185357952.html